The estimated Net Worth of Heather C Getz is at least 4.12 百万$ dollars as of 31 January 2019. Ms. Getz owns over 10,590 units of HeartBeam Inc stock worth over 204,865$ and over the last 11 years he sold BEAT stock worth over 2,241,013$. In addition, he makes 1,671,100$ as Chief Financial Officer、 Executive Vice President、 Chief Administrative Officer at HeartBeam Inc.
Heather has made over 15 trades of the HeartBeam Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 10,590 units of BEAT stock worth 29,652$ on 31 January 2019.
The largest trade he's ever made was exercising 93,383 units of HeartBeam Inc stock on 25 January 2019 worth over 251,200$. On average, Heather trades about 11,737 units every 30 days since 2014. As of 31 January 2019 he still owns at least 91,051 units of HeartBeam Inc stock.
You can see the complete history of Ms. Getz stock trades at the bottom of the page.
MS. Heather C. Getz CPA serves as Chief Financial Officer, Executive Vice President, Chief Administrative Officer of the Company. Ms. Getz was appointed Executive Vice President and Chief Financial Officer in May 2017. Ms. Getz joined us in May 2009 and previously served as our Senior Vice President and Chief Financial Officer and prior to that our Vice President of Finance. From April 2008 to May 2009, Ms. Getz was Vice President of Finance at Alita Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, where she was responsible for all areas of finance, accounting and information systems. Prior to joining Alita Pharmaceuticals, Inc., from March 2002 to April 2008, Ms. Getz held various financial leadership positions at VIASYS Healthcare Inc., a healthcare technology company acquired by Cardinal Health, Inc. in July 2007, including directing the company’s global financial planning, budgeting and analysis, and external reporting functions. From June 1997 to February 2002, Ms. Getz began her career at Sunoco, Inc., where she held various positions of increasing responsibility. Ms. Getz received her undergraduate degree in Accountancy and a Master of Business Administration degree from Villanova University.
As the Chief Financial Officer、 Executive Vice President、 Chief Administrative Officer of HeartBeam Inc, the total compensation of Heather Getz at HeartBeam Inc is 1,671,100$. There are 1 executives at HeartBeam Inc getting paid more, with Joseph Capper having the highest compensation of 4,133,160$.
Heather Getz is 45, he's been the Chief Financial Officer、 Executive Vice President、 Chief Administrative Officer of HeartBeam Inc since 2019. There are 17 older and no younger executives at HeartBeam Inc. The oldest executive at HeartBeam Inc is Robert Rubin, 74, who is the Independent Director.
Heather's mailing address filed with the SEC is 137 PORTLAND ST., 4TH FLOOR, BOSTON, MA, 02114.
Over the last 11 years, insiders at HeartBeam Inc have traded over 23,124,978$ worth of HeartBeam Inc stock and bought 31,500 units worth 221,145$ . The most active insiders traders include Joseph H Capper、Heather C Getz、Willem Elfrink. On average, HeartBeam Inc executives and independent directors trade stock every 32 days with the average trade being worth of 55,046$. The most recent stock trade was executed by Urioste George De on 6 September 2024, trading 1,674 units of BEAT stock currently worth 3,917$.
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient’s 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
HeartBeam Inc executives and other stock owners filed with the SEC include: